Walleye Capital’s Nu Skin NUS Stock Holding History

Walleye Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-27,700	Closed	-$292K	–	5708
2024 Q2	$292K	Buy	27,700 +12,300	+80%	+$156K	﹤0.01%	3999
2024 Q1	$213K	Buy	15,400 +800	+5%	+$12.5K	﹤0.01%	3939
2023 Q4	$284K	Buy	+14,600	New	+$269K	﹤0.01%	3409

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's NUS Position: Q3 2025 in Review

Walleye Capital sold out of Nu Skin (NUS) in Q3 2025, closing a stake of 159,478 shares — an estimated $1.27M sold.

Walleye Capital first reported a position in NUS in Q2 2019 and held it in 15 quarters. The position peaked at $3.39M in Q1 2024. 194 funds tracked by Wall St. Rank hold NUS as of Q3 2025.

Walleye Capital reported no remaining Nu Skin position as of Q3 2025 after selling out during the quarter.
Walleye Capital sold 159,478 Nu Skin shares in Q3 2025, an estimated $1.27M.
Walleye Capital first reported a position in Nu Skin in Q2 2019 and held it in 15 quarters.
Walleye Capital's Nu Skin position peaked at $3.39M in Q1 2024.
194 funds tracked by Wall St. Rank held Nu Skin as of Q3 2025.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.